Marksans Pharma LimitedNSE: MARKSANS

Press Release Nov 22 2024

· Issued by Marksans Pharma Limited

Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated November 22, 2024, titled "USFDA approval for Loratadine USP 10mg tablets".

View Attachment

6ix hasn’t read this filing yet.

Marksans Pharma Limited on 6ix

Earlier from Marksans Pharma

Later from Marksans Pharma

All Marksans Pharma news releases